Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)DECIDE-HIPNCT07687108
Improving Shared DECISion-making in oldEr Hip Fracture Patients Living With Frailty
An observational study of Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures) and Hip Fractures (ICD-10 72.01-72.2), run by University of Southampton at 1 site in United Kingdom.
Trial summary
Title Improving shared decision-making in older hip fracture patients living with frailty Aim To use routinely information normally collected by the NHS, and interviews with patients, families, and healthcare professionals, to produce an aid to help patients make decisions about hip fracture treatment that reflects… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Hip Fractures (ICD-10 72.01-72.2), Hip Fracture
- How many people
- 42 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Oct 2026to 7 Feb 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Phase 1 1. Older adults (aged over 65) with fragility fractures of the hip Phase 2 1. Older adults with fragility fractures of the hip 2. Relatives and carers of older adults with fragility fractures of the hip 3. UK health professionals caring for older adults with fragility fractures of the hip 4. European health professionals caring for older adults with fragility fractures of the hip Phase 3 1. Older adults with fragility fractures of the hip admitted to University Hospital Southampton
Who may be able to join
- Aged ≥65
- Fragility fracture of the proximal femur defined as a fall from standing height or less from August 2021 to present
- Electronic frailty index (eFI) or eFI2 score in the 12 months preceding hip fracture for CPRD data; American Society of Anesthesiologists (ASA) Physical Status grade for NHFD data
- Age ≥65
- Admitted to a trauma and orthopaedic ward at University Hospital Southampton following a fragility fracture of the hip
- Age ≥18
Show all 15Show fewer
- Carer or next of kin for a person meeting the eligibility criteria for group 1
- Registered healthcare professionals involved in acute hip fracture management decisions including physicians, orthopaedic surgeons, anaesthetists, nurses and allied health professionals.
- Currently work or have worked within the past 6 months at University Hospital Southampton
- Group 4 - European healthcare professionals
- Registered healthcare professionals involved in acute hip fracture management decisions including physicians, orthopaedic surgeons, nurses and allied health professionals.
- Currently work or have worked within the past 6 months in trauma and orthopaedics or orthogeriatrics at a European hospital
- Eligibility criteria - Phase 3
- Age ≥65
- Admitted to a trauma and orthopaedic ward at University Hospital Southampton following a fragility fracture of the hip
Who cannot join
- Age <65
- Femoral shaft or distal femur fractures, periprosthetic fractures, and pathological fractures.
- PHASE 2 ELIGIBILITY CRITERIA
- Group 1 - Patients
- Distal femoral shaft fractures, periprosthetic fractures, pathological fractures
- Non-fragility fractures, defined as a fracture due to a force greater than falling from a standing height
Show all 12Show fewer
- Group 2 - Families and carers
- Do not have the capacity to consent to participation in the study.
- Group 3 - Local healthcare professionals
- Distal femoral shaft fractures, periprosthetic fractures, pathological fractures
- Non-fragility fractures, defined as a fracture due to a force greater than falling from a standing height
- Do not have the capacity to consent in accordance with the Mental Capacity Act 2005
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, SO16 6YD
Liam L Jones, BMBS, 02381206134 ext. 6134, L.Jones@soton.ac.uk
About this study
Official title: The DECIDE-HIP Study: Improving Shared DECISion-making in oldEr Hip Fracture Patients Living With Frailty
Title Improving shared decision-making in older hip fracture patients living with frailty
Aim To use routinely information normally collected by the NHS, and interviews with patients, families, and healthcare professionals, to produce an aid to help patients make decisions about hip fracture treatment that reflects what is important to them.
Read more
Background Breaking a hip after a fall is common in older adults. The risk of dying is high after a hip fracture, especially if the person does not have surgery. Most UK patients have surgery even if they are very frail. Patients who are at a very high risk of dying still have surgery to help control the pain. However, this is not the same in all countries and recent studies show pain can be well controlled with medications and nerve-numbing drugs.
Whilst the risk of dying is still much higher without surgery, to some frail older adults there are more important things to them than living longer like being able to walk and look after themselves. Some people may choose end-of-care instead of an operation if surgery means they won't be able to do these things afterwards. To help frail older people make the decision that is best for them, they need information about all treatment options and what their life is likely to be like after. This information needs to be easy to understand.
Why the research is important This research will give frail older people with hip fractures the information they need to make decisions that focus on what is most important to them. We will make a guide to present the information in a way that is easy to understand and will help patients make decisions alongside healthcare professionals.
Design
We will complete 4 Work Packages (WPs):
WP1: What do we already know about the link between frailty and the ability for older people to move and look after themselves after hip fracture? • We will review all current studies that look at what frail older peoples' lives are like after having a hip fracture and combine all the information in these studies. This will stop us from repeating work already done and show us any gaps in knowledge.
WP2: Can we use how frail someone is and other information to predict their ability to move and look after themselves after a hip fracture?
- We will use data the NHS collects to explore links between frailty, health and social issues, and a person's ability to move, walk, and care for themselves after hip fracture. I will see if these factors predict which people will do better after a hip fracture.
WP3: What factors affect treatment decisions in frail adults with a hip fracture? • We will interview older hip fracture patient with frailty, families, and healthcare staff to explore how decisions are made about hip fractures and how we can improve this.
WP4: Creating and testing an aid to help older patients with frailty make decisions about hip fracture treatment
- We will work with patients to design a decision aid to improve shared decision-making in hip fracture care. We will test out the aid on orthopaedic wards in Southampton and improve it based on feedback.
Read the detailed description
WP1 - Functional outcomes and quality of life following hip fracture in older adults living with different degrees of frailty: A systematic review Aim To synthesise the literature on the relationship between frailty and functional and QoL outcomes in patients presenting with hip fracture.
Rationale Existing literature on the link between frailty and function after hip fracture is limited. This review will guide WP2's design, ensuring it addresses current gaps.
Methods and design I will work with my supervisory team and university librarians to develop a search strategy. Databases searched will include Embase, MEDLINE, CINAHL, and Web of Science Core Collection. Grey literature (e.g. conference abstracts) will be searched using Grey Matters. Bibliographies of included studies will be screened, and all databases searched from earliest record to present.
Inclusion and exclusion criteria Inclusion Criteria Exclusion Criteria Population Age ≥65 Frailty as measured by a validated screening tool Diagnosed with an acute hip fracture including proximal femoral shaft, head, and neck fractures whether this results in admission or not Age <65 Studies that do not report frailty status Distal femoral fractures, impacted femoral head fractures, periprosthetic fractures, pathological fractures Exposure Frailty defined by a validated scoring system within the study No measure of frailty Outcomes Mortality, Mobility, Functional status, Health-related QoL, Discharge destination Studies that do not report at least one of the relevant outcomes Study design Observational studies including prospective and retrospective cohort studies, Randomised controlled trials Case reports, review articles, animal and in vitro studies, editorials, book chapters or extracts Table 1. Inclusion and exclusion criteria for WP1 Data extraction Abstracts will be double screened by 2 researchers in Rayyan.ai, with duplicates removed and disagreements resolved by my supervisor. Full abstract texts will then be double screened against criteria. Extracted data will include title, journal, publication year, authors, study country, design, participant details, study aims, sample size, outcomes, measurement tools, results, and statistical analyses.
Assessment of bias The Joanna Briggs Institute (JBI) critical appraisal checklists for the respective study types included will be used to summarise the risk of bias for the included studies.
Data synthesis I will follow the PRISMA 2020 checklist. While meta-analysis is preferred, heterogeneity may preclude it. Cochran's Q test and the I² index will assess heterogeneity and synthesis without meta-analysis (SWiM) used if necessary.
WP2 - The predictive value of frailty on functional status following fragility fracture of the hip in older adults: A retrospective cohort study Aims To identify prognostic factors and assess the relationship between frailty and functional decline following hip fracture in older adults.
Rationale Most patients with hip fractures receive operative management regardless of frailty due to data showing high mortality with non-operative management. However, mortality is not the only concern to patients. My PPI work and existing studies highlight functional status as equally important. This study will provide functional outcome data across frailty levels to support informed decision-making.
Methods and design I will conduct a retrospective cohort study using routinely collected data from the Wessex Secure Data Environment (SDE) and the Clinical Practice Research Datalink (CPRD). I will identify older adults who had fragility hip fractures from August 2021-present to assess the relationship between frailty status and functional status. Prior to August 2021 hip fracture incidence was lower than expected due the Covid-19 pandemic(33), which may have influenced outcomes. The Barthel Index (BI) will be used assess functional status as it been validated in this setting(34).
Inclusion and exclusion criteria Eligible Ineligible Age ≥65 Fragility fracture of the proximal femur defined as a fall from standing height or less from August 2021 to present Age <65 Femoral shaft or distal femur fractures, periprosthetic fractures, or pathological fractures, stable impacted femoral head fractures, or high impact trauma Table 2. Inclusion and exclusion criteria for WP2 Data collection Data will be collected from the Wessex SDE and CPRD. Primary outcomes include functional status via the Barthel Index (BI) at discharge, 3, and 6 months. Secondary outcomes include mortality, days alive and at home, discharge destination and residential location at 3 and 6 months. I will identify other important secondary outcomes with PPI input.
I will collect data on variables that may influence the primary outcome, including age, sex, residential status, ethnicity, surgery type, time to surgery, admission day, fracture type, prosthesis type, surgeon and anaesthetist seniority, dementia diagnosis, baseline BI, and Charlson Comorbidity Index (CCI).
Data analysis I will perform linear regression to assess associations between frailty status and other risk factors, followed by linear regression to evaluate links between frailty and functional status at discharge, 3, and 6 months. A multivariate analysis will then explore relationships between all predictors and the primary outcome.
WP3 - Decision-making in the management of hip fractures in older adults living with frailty: a qualitative study Aim To explore decision-making processes in hip fracture management in older adults living with frailty, including exploring barriers to discussing non-operative care.
Rationale To support shared decision-making in hip fracture care, it is vital to understand key factors and barriers in discussing management options, including non-operative management. I will explore this through interviews with four groups: patients, their families/carers, NHS clinicians, and European clinicians.
Methods and design I will conduct a qualitative study using semi-structured interviews. Reflexive thematic analysis will enable me to critically examine interpretations of identified themes in the context of my perspective as a geriatrician(35).
Participant group Recruitment method Group 1 - Age ≥65 admitted to University Hospital Southampton (UHS) following a fragility hip fracture Screen new admissions to UHS orthopaedics using EPR system Group 2 - Families or non-paid carers in addition to group 1 participants Seek permission from group 1 participants to contact families and carers Group 3 - Registered healthcare professionals involved in acute hip fracture management decisions including physicians, orthopaedic surgeons, nurses and allied health professionals Email invitations to relevant professional groups using UHS departmental email address books and posters inviting potential participants displayed on orthopaedic wards Group 4 - Registered healthcare professionals (as per group 3) from other European countries Invitation emails to be disseminated via contacts from the British Geriatrics Society and the European Geriatric Medicine Society Table 3. Participants and recruitment for WP3 I will explore factors influencing hip fracture decision-making. Meetings with individual interviewees will last 45 minutes, using guides developed with PPI input and clinicians. Group 1 interviews will be at the bedside or by phone post-discharge; Groups 2 and 3 in a private office, by phone, or video call; Group 4 by phone or video call. Interviews will be recorded and transcribed.
Data analysis Interview transcripts will be thematically analysed using Braun and Clarke's steps(36). Themes will be compared within and across groups. NVivo will be used to manage data for thematic analysis. A PPI group will review coding and themes to ensure they reflect participants' views. I will be supported in qualitative data analysis by my supervisor Dr Natalie Cox, who has extensive experience in this field.
Sample size I will recruit until data saturation is reached. Previous reviews suggest this occurs at around 9 interviewees per group(37). However, exact numbers of interviewees will depend on data quality and richness. As groups 3 and 4 include varied professional roles, I will aim for at least 3 participants per profession, as suggested in a 2024 review, resulting in a target sample of 12 for these groups(38).
WP4 - Co-design and pilot testing of a patient decision aid to support shared decision-making for hip fracture management Aim Co-design a patient decision aid to support shared decision-making in hip fracture management with key stakeholders including patients, carers and clinicians, then pilot implementation locally to assess acceptability to these stakeholders.
Rationale To make informed decisions, patients need to understand all the possible treatment options, the likely outcomes with each option, and what the treatments involve. How information is presented to patients can vary between clinicians. Patient decision aids standardise information presented in accessible, comprehensible formats.
Patient decision aid development I will develop a paper-based patient decision aid following the development processes recommended by the International Patient Decision Aid Standards (IPDAS) framework(39). Decision support needs, patient priorities, and outcome data identified in preceding WPs will inform the design of a draft decision aid.
Patient, clinician, and carer participants from WP3 will be invited to form a focus group to review the draft decision aid. An iterative process of at least 3 cycles will be used to further develop the decision aid as per IPDAS(40). Nominal Group Technique (NGT), a structured consensus development technique, will be used to generate consensus on the final draft aid that will be pilot tested(41).
Figure 1. Model development process adapted from IPDAS Systematic Development of Patient Decision Aids flowchart(40).
Pilot testing A quasi-experimental pre- and post-test study will use the Decisional Conflict Scale (DCS), a validated tool to measure perceptions of uncertainty in health-related decision making(42), to assess the effectiveness of the patient decision aid. All older hip fracture patients over a 4-week period on orthopaedic wards at UHS will be invited to complete the DCS. Pilot implementation of the decision aid will then start, and subsequent patients, over 4 weeks, will be invited to complete the DCS. Difference in mean DCS scores before and after the pilot will be compared using a t-test.
Acceptability to clinicians of using the decision-aid will be assessed through a questionnaire co-designed with stakeholders, using the Theoretical Framework of Acceptability model(43) which has been used to inform development of acceptability measures in surgical settings(44).
- Conditions
- Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Hip Fractures (ICD-10 72.01-72.2), Hip Fracture, Hip Fracture, Post Surgery Recovery, Muscle Resilience
- Keywords
- functional outcomes, frailty, decision aid, shared decision making, qualitative, semi-structured interviews, routinely collected data, hip fracture, quality of life, function, mobility
- Medical subject headings
- Hip Fractures, Frailty
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in functional status
Change in the numbers of healthcare record codes before and after hip fracture indicating difficulties with activities of daily living (ADLs) and physical disability as markers of functional status.
Measured: At 3 months, 6 months, and 12 months after hip fracture date
Secondary outcomes (4)
Mortality
1 year mortality rate as recorded in relevant database.
Measured: Mortality rate at 1 year post hip fracture.
Days alive and at home
Days alive and at home at 90 and 365 days
Measured: 90 and 365 days from date of hip fracture
Discharge destination
Discharge destination (home/pre-admission residence, new residential home, new nursing home, rehabilitation facility)
Measured: Residential location day 1 after acute hospital discharge following hip fracture
Residential location
Residential location at 3, 6, and 12 months (own home, residential home, nursing home)
Measured: 3, 6, and 12 months following hip fracture date
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jul 2026
- Study start1 Oct 2026 (estimated)
- Primary completion7 Sep 2028 (estimated)
- Study completion7 Feb 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Southampton
- Sponsor type
- University, hospital or other
- Collaborators
- NIHR Applied Research Collaboration Wessex
- Responsible party
- Principal investigator, Liam Jones, University of Southampton
- Investigators
- Liam L Jones, BMBS, MRCP (UK), Study chair, University of Southampton
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07687108
- Sponsor's protocol ID
- 112201
- Other IDs
- IRAS Project ID: 371723
- Acronym
- DECIDE-HIP
- Status last verified
- Jun 2026
- First submitted
- 24 Jun 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The DECIDE-HIP Study: Improving Shared DECISion-making in oldEr Hip Fracture Patients Living With Frailty
- ClinicalTrials.gov ID
- NCT07687108
- Acronym / sponsor ID
- DECIDE-HIP / 112201
- Conditions
- Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Hip Fractures (ICD-10 72.01-72.2), Hip Fracture, Hip Fracture, Post Surgery Recovery, Muscle Resilience
- Keywords
- functional outcomes, frailty, decision aid, shared decision making, qualitative, semi-structured interviews, routinely collected data, hip fracture
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- University of SouthamptonUniversity, hospital or other
- Collaborators
- NIHR Applied Research Collaboration Wessex
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 7 Sep 2028 (estimated)
- Study completion
- 7 Feb 2029 (estimated)
- First posted
- 7 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Title Improving shared decision-making in older hip fracture patients living with frailty
Aim To use routinely information normally collected by the NHS, and interviews with patients, families, and healthcare professionals, to produce an aid to help patients make decisions about hip fracture treatment that reflects what is important to them.
Background Breaking a hip after a fall is common in older adults. The risk of dying is high after a hip fracture, especially if the person does not have surgery. Most UK patients have surgery even if they are very frail. Patients who are at a very high risk of dying still have surgery to help control the pain. However, this is not the same in all countries and recent studies show pain can be well controlled with medications and nerve-numbing drugs.
Whilst the risk of dying is still much higher without surgery, to some frail older adults there are more important things to them than living longer like being able to walk and look after themselves. Some people may choose end-of-care instead of an operation if surgery means they won't be able to do these things afterwards. To help frail older people make the decision that is best for them, they need information about all treatment options and what their life is likely to be like after. This information needs to be easy to understand.
Why the research is important This research will give frail older people with hip fractures the information they need to make decisions that focus on what is most important to them. We will make a guide to present the information in a way that is easy to understand and will help patients make decisions alongside healthcare professionals.
Design
We will complete 4 Work Packages (WPs):
WP1: What do we already know about the link between frailty and the ability for older people to move and look after themselves after hip fracture? • We will review all current studies that look at what frail older peoples' lives are like after having a hip fracture and combine all the information in these studies. This will stop us from repeating work already done and show us any gaps in knowledge.
WP2: Can we use how frail someone is and other information to predict their ability to move and look after themselves after a hip fracture?
- We will use data the NHS collects to explore links between frailty, health and social issues, and a person's ability to move, walk, and care for themselves after hip fracture. I will see if these factors predict which people will do better after a hip fracture.
WP3: What factors affect treatment decisions in frail adults with a hip fracture? • We will interview older hip fracture patient with frailty, families, and healthcare staff to explore how decisions are made about hip fractures and how we can improve this.
WP4: Creating and testing an aid to help older patients with frailty make decisions about hip fracture treatment
- We will work with patients to design a decision aid to improve shared decision-making in hip fracture care. We will test out the aid on orthopaedic wards in Southampton and improve it based on feedback.
Detailed description
WP1 - Functional outcomes and quality of life following hip fracture in older adults living with different degrees of frailty: A systematic review Aim To synthesise the literature on the relationship between frailty and functional and QoL outcomes in patients presenting with hip fracture.
Rationale Existing literature on the link between frailty and function after hip fracture is limited. This review will guide WP2's design, ensuring it addresses current gaps.
Methods and design I will work with my supervisory team and university librarians to develop a search strategy. Databases searched will include Embase, MEDLINE, CINAHL, and Web of Science Core Collection. Grey literature (e.g. conference abstracts) will be searched using Grey Matters. Bibliographies of included studies will be screened, and all databases searched from earliest record to present.
Inclusion and exclusion criteria Inclusion Criteria Exclusion Criteria Population Age ≥65 Frailty as measured by a validated screening tool Diagnosed with an acute hip fracture including proximal femoral shaft, head, and neck fractures whether this results in admission or not Age <65 Studies that do not report frailty status Distal femoral fractures, impacted femoral head fractures, periprosthetic fractures, pathological fractures Exposure Frailty defined by a validated scoring system within the study No measure of frailty Outcomes Mortality, Mobility, Functional status, Health-related QoL, Discharge destination Studies that do not report at least one of the relevant outcomes Study design Observational studies including prospective and retrospective cohort studies, Randomised controlled trials Case reports, review articles, animal and in vitro studies, editorials, book chapters or extracts Table 1. Inclusion and exclusion criteria for WP1 Data extraction Abstracts will be double screened by 2 researchers in Rayyan.ai, with duplicates removed and disagreements resolved by my supervisor. Full abstract texts will then be double screened against criteria. Extracted data will include title, journal, publication year, authors, study country, design, participant details, study aims, sample size, outcomes, measurement tools, results, and statistical analyses.
Assessment of bias The Joanna Briggs Institute (JBI) critical appraisal checklists for the respective study types included will be used to summarise the risk of bias for the included studies.
Data synthesis I will follow the PRISMA 2020 checklist. While meta-analysis is preferred, heterogeneity may preclude it. Cochran's Q test and the I² index will assess heterogeneity and synthesis without meta-analysis (SWiM) used if necessary.
WP2 - The predictive value of frailty on functional status following fragility fracture of the hip in older adults: A retrospective cohort study Aims To identify prognostic factors and assess the relationship between frailty and functional decline following hip fracture in older adults.
Rationale Most patients with hip fractures receive operative management regardless of frailty due to data showing high mortality with non-operative management. However, mortality is not the only concern to patients. My PPI work and existing studies highlight functional status as equally important. This study will provide functional outcome data across frailty levels to support informed decision-making.
Methods and design I will conduct a retrospective cohort study using routinely collected data from the Wessex Secure Data Environment (SDE) and the Clinical Practice Research Datalink (CPRD). I will identify older adults who had fragility hip fractures from August 2021-present to assess the relationship between frailty status and functional status. Prior to August 2021 hip fracture incidence was lower than expected due the Covid-19 pandemic(33), which may have influenced outcomes. The Barthel Index (BI) will be used assess functional status as it been validated in this setting(34).
Inclusion and exclusion criteria Eligible Ineligible Age ≥65 Fragility fracture of the proximal femur defined as a fall from standing height or less from August 2021 to present Age <65 Femoral shaft or distal femur fractures, periprosthetic fractures, or pathological fractures, stable impacted femoral head fractures, or high impact trauma Table 2. Inclusion and exclusion criteria for WP2 Data collection Data will be collected from the Wessex SDE and CPRD. Primary outcomes include functional status via the Barthel Index (BI) at discharge, 3, and 6 months. Secondary outcomes include mortality, days alive and at home, discharge destination and residential location at 3 and 6 months. I will identify other important secondary outcomes with PPI input.
I will collect data on variables that may influence the primary outcome, including age, sex, residential status, ethnicity, surgery type, time to surgery, admission day, fracture type, prosthesis type, surgeon and anaesthetist seniority, dementia diagnosis, baseline BI, and Charlson Comorbidity Index (CCI).
Data analysis I will perform linear regression to assess associations between frailty status and other risk factors, followed by linear regression to evaluate links between frailty and functional status at discharge, 3, and 6 months. A multivariate analysis will then explore relationships between all predictors and the primary outcome.
WP3 - Decision-making in the management of hip fractures in older adults living with frailty: a qualitative study Aim To explore decision-making processes in hip fracture management in older adults living with frailty, including exploring barriers to discussing non-operative care.
Rationale To support shared decision-making in hip fracture care, it is vital to understand key factors and barriers in discussing management options, including non-operative management. I will explore this through interviews with four groups: patients, their families/carers, NHS clinicians, and European clinicians.
Methods and design I will conduct a qualitative study using semi-structured interviews. Reflexive thematic analysis will enable me to critically examine interpretations of identified themes in the context of my perspective as a geriatrician(35).
Participant group Recruitment method Group 1 - Age ≥65 admitted to University Hospital Southampton (UHS) following a fragility hip fracture Screen new admissions to UHS orthopaedics using EPR system Group 2 - Families or non-paid carers in addition to group 1 participants Seek permission from group 1 participants to contact families and carers Group 3 - Registered healthcare professionals involved in acute hip fracture management decisions including physicians, orthopaedic surgeons, nurses and allied health professionals Email invitations to relevant professional groups using UHS departmental email address books and posters inviting potential participants displayed on orthopaedic wards Group 4 - Registered healthcare professionals (as per group 3) from other European countries Invitation emails to be disseminated via contacts from the British Geriatrics Society and the European Geriatric Medicine Society Table 3. Participants and recruitment for WP3 I will explore factors influencing hip fracture decision-making. Meetings with individual interviewees will last 45 minutes, using guides developed with PPI input and clinicians. Group 1 interviews will be at the bedside or by phone post-discharge; Groups 2 and 3 in a private office, by phone, or video call; Group 4 by phone or video call. Interviews will be recorded and transcribed.
Data analysis Interview transcripts will be thematically analysed using Braun and Clarke's steps(36). Themes will be compared within and across groups. NVivo will be used to manage data for thematic analysis. A PPI group will review coding and themes to ensure they reflect participants' views. I will be supported in qualitative data analysis by my supervisor Dr Natalie Cox, who has extensive experience in this field.
Sample size I will recruit until data saturation is reached. Previous reviews suggest this occurs at around 9 interviewees per group(37). However, exact numbers of interviewees will depend on data quality and richness. As groups 3 and 4 include varied professional roles, I will aim for at least 3 participants per profession, as suggested in a 2024 review, resulting in a target sample of 12 for these groups(38).
WP4 - Co-design and pilot testing of a patient decision aid to support shared decision-making for hip fracture management Aim Co-design a patient decision aid to support shared decision-making in hip fracture management with key stakeholders including patients, carers and clinicians, then pilot implementation locally to assess acceptability to these stakeholders.
Rationale To make informed decisions, patients need to understand all the possible treatment options, the likely outcomes with each option, and what the treatments involve. How information is presented to patients can vary between clinicians. Patient decision aids standardise information presented in accessible, comprehensible formats.
Patient decision aid development I will develop a paper-based patient decision aid following the development processes recommended by the International Patient Decision Aid Standards (IPDAS) framework(39). Decision support needs, patient priorities, and outcome data identified in preceding WPs will inform the design of a draft decision aid.
Patient, clinician, and carer participants from WP3 will be invited to form a focus group to review the draft decision aid. An iterative process of at least 3 cycles will be used to further develop the decision aid as per IPDAS(40). Nominal Group Technique (NGT), a structured consensus development technique, will be used to generate consensus on the final draft aid that will be pilot tested(41).
Figure 1. Model development process adapted from IPDAS Systematic Development of Patient Decision Aids flowchart(40).
Pilot testing A quasi-experimental pre- and post-test study will use the Decisional Conflict Scale (DCS), a validated tool to measure perceptions of uncertainty in health-related decision making(42), to assess the effectiveness of the patient decision aid. All older hip fracture patients over a 4-week period on orthopaedic wards at UHS will be invited to complete the DCS. Pilot implementation of the decision aid will then start, and subsequent patients, over 4 weeks, will be invited to complete the DCS. Difference in mean DCS scores before and after the pilot will be compared using a t-test.
Acceptability to clinicians of using the decision-aid will be assessed through a questionnaire co-designed with stakeholders, using the Theoretical Framework of Acceptability model(43) which has been used to inform development of acceptability measures in surgical settings(44).
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Phase 1 1. Older adults (aged over 65) with fragility fractures of the hip Phase 2 1. Older adults with fragility fractures of the hip 2. Relatives and carers of older adults with fragility fractures of the hip 3. UK health professionals caring for older adults with fragility fractures of the hip 4. European health professionals caring for older adults with fragility fractures of the hip Phase 3 1. Older adults with fragility fractures of the hip admitted to University Hospital Southampton
Key inclusion criteria (15 listed)
- Aged ≥65
- Fragility fracture of the proximal femur defined as a fall from standing height or less from August 2021 to present
- Electronic frailty index (eFI) or eFI2 score in the 12 months preceding hip fracture for CPRD data; American Society of Anesthesiologists (ASA) Physical Status grade for NHFD data
- Age ≥65
- Admitted to a trauma and orthopaedic ward at University Hospital Southampton following a fragility fracture of the hip
Key exclusion criteria (12 listed)
- Age <65
- Femoral shaft or distal femur fractures, periprosthetic fractures, and pathological fractures.
- PHASE 2 ELIGIBILITY CRITERIA
- Group 1 - Patients
- Distal femoral shaft fractures, periprosthetic fractures, pathological fractures
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Change in functional status
Time frame: At 3 months, 6 months, and 12 months after hip fracture date
Change in the numbers of healthcare record codes before and after hip fracture indicating difficulties with activities of daily living (ADLs) and physical disability as markers of functional status.
4 secondary outcomes
Mortality
Time frame: Mortality rate at 1 year post hip fracture.
Days alive and at home
Time frame: 90 and 365 days from date of hip fracture
Discharge destination
Time frame: Residential location day 1 after acute hospital discharge following hip fracture
Residential location
Time frame: 3, 6, and 12 months following hip fracture date
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Individual participant dataSharing planned: Yes
Related trials for Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)
RecruitingObservational study
Cohort Study on the Prognosis and Influencing Factors in Elderly Patients With Hip Fractures in Multicenter of China
Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)
Not yet recruiting
FICB for Hip Fracture Pain in Elderly
Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain
Active, not recruiting
PENG vs FICB for Hip Fracture in ED Patients
Femoral Neck Fractures, Intertrochanteric Fractures
Not yet recruiting
How TENS Affects Pain, Medication Use, and Muscle Function in Older Adults With Hip Fractures
Hip Fractures, Femoral Neck Fractures
Recruiting
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
Hip Fractures, Femoral Neck Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Liam L Jones, BMBS, MRCP (UK) study chair
University of Southampton
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures) and Hip Fractures (ICD-10 72.01-72.2), run by University of Southampton at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Liam L Jones, BMBS (+442381206134, L.Jones@soton.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in functional status (time frame: At 3 months, 6 months, and 12 months after hip fracture date). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026; AzTrials last refreshed its copy on 7 Nov 2026.